- Presentations
- 3
- Markets
- 1
Sandostatin is a brand of Octreotide marketed by Novartis Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Octreotide
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 100 mcg/1 mL injection, 50 mcg/1 mL injection, 500 mcg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Sandostatin 100 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
| Sandostatin 50 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
| Sandostatin 500 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Octreotide.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Sandostatin
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.